Glaukos Corp.
Joseph E Gilliam (PRESIDENT & COO) sells GKOS shares
About this filing
Glaukos Corp. (GKOS) filed Form 4 (insider transaction) with the SEC on Nov 16, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- Joseph E Gilliam · PRESIDENT & COO
Rule 10b5-1 plan · adopted Aug 13, 2026
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 12, 2026 | M · exercise or conversion of a derivativeFootnotes F1 | +2,475 | $69.30 | $171,517.50 | 74,077 | Direct |
| Nov 12, 2026 | M · exercise or conversion of a derivativeFootnotes F1 | +7,500 | $48.46 | $363,450.00 | 81,577 | Direct |
| Nov 12, 2026 | M · exercise or conversion of a derivativeFootnotes F1 | +11,250 | $55.18 | $620,775.00 | 92,827 | Direct |
| Nov 12, 2026 | M · exercise or conversion of a derivativeFootnotes F1 | +16,192 | $55.18 | $893,474.56 | 109,019 | Direct |
| Nov 12, 2026 | M · exercise or conversion of a derivativeFootnotes F1 | +7,500 | $48.46 | $363,450.00 | 116,519 | Direct |
| Nov 12, 2026 | S · open-market saleFootnotes F2, F3, F1 | −2,402 | $243.41 | $584,670.82 | 114,117 | Direct |
| Nov 12, 2026 | S · open-market saleFootnotes F2, F4, F1 | −3,700 | $244.49 | $904,613.00 | 110,417 | Direct |
| Nov 12, 2026 | S · open-market saleFootnotes F2, F5, F1 | −8,015 | $245.77 | $1,969,846.55 | 102,402 | Direct |
| Nov 12, 2026 | S · open-market saleFootnotes F2, F6, F1 | −18,440 | $246.49 | $4,545,275.60 | 83,962 | Direct |
| Nov 12, 2026 | S · open-market saleFootnotes F2, F7, F1 | −12,060 | $247.50 | $2,984,850.00 | 71,902 | Direct |
| Nov 12, 2026 | S · open-market saleFootnotes F2, F8, F1 | −300 | $248.42 | $74,526.00 | 71,602 | Direct |
| Nov 12, 2026 | M · exercise or conversion of a derivativeStock Option (Right to Buy)Footnotes F9, F10 | −2,475 | $0.00 | $0.00 | 825 | Direct |
| Nov 12, 2026 | M · exercise or conversion of a derivativeStock Option (Right to Buy)Footnotes F9, F10 | −7,500 | $0.00 | $0.00 | 19,251 | Direct |
| Nov 12, 2026 | M · exercise or conversion of a derivativeStock Option (Right to Buy)Footnotes F9, F11 | −7,500 | $0.00 | $0.00 | 19,251 | Direct |
| Nov 12, 2026 | M · exercise or conversion of a derivativeStock Option (Right to Buy)Footnotes F9, F12 | −11,250 | $0.00 | $0.00 | 19,463 | Direct |
| Nov 12, 2026 | M · exercise or conversion of a derivativeStock Option (Right to Buy)Footnotes F9, F13 | −16,192 | $0.00 | $0.00 | 35,283 | Direct |
Footnotes
- F1 Includes 40,039 restricted stock units that have not yet vested or been delivered to the Reporting Person.
- F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2026.
- F3 This transaction was executed in multiple trades at prices ranging from $242.96 to $243.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4 This transaction was executed in multiple trades at prices ranging from $244.00 to $245.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5 This transaction was executed in multiple trades at prices ranging from $245.06 to $246.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6 This transaction was executed in multiple trades at prices ranging from $246.07 to $247.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7 This transaction was executed in multiple trades at prices ranging from $247.08 to $248.08. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8 This transaction was executed in multiple trades at prices ranging from $248.34 to $248.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9 The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2026.
- F10 These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years.
- F11 Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 22, 2023, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period.
- F12 Represents a portion of an option to purchase shares of common stock previously granted by the Issuer to the Reporting Person on March 24, 2022 in connection with his promotion to President and Chief Operating Officer, the vesting of which was subject to the Issuer's achievement of certain multi-year performance goals.
- F13 Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period.
More GKOS filings
- 4
Filed Nov 20, 2026
- 4
Filed Nov 20, 2026
- 4
Filed Nov 19, 2026
- 4
Filed Nov 18, 2026
- 144
Filed Nov 18, 2026
- 144
Filed Nov 18, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.